The other signature includes MYOIGthat constitutes the minor histocompatibility antigen HA-2 that binds to MHC class I molecules, makes the antigens recognizable by CD8 + T cells in tumor cells, and allows the destruction of harmful tumor cells [29, 30]. This evidence concerns the gene CD8A and neoplasm.